Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Clin Colorectal Cancer. 2018 Aug 20;18(1):44–51. doi: 10.1016/j.clcc.2018.08.001

Table 3:

Key elements to consider including in oncology clinical trials (Adapted from ECOG Baseline and Follow up Cardiovascular Form, see supplemental appendix)

History of Diagnosed CVD Symptoms Suggestive of CVD Physical Exam Findings Lab and Imaging Data Cardiac Medications
Coronary artery disease
  • Myocardial Infarct (date)

  • Revascularization history (Percutaneous coronary intervention of coronary artery bypass graft surgery)

  • Angina class

Chest pain at rest or with exertion
Shortness of breath at rest or with exertion Orthopnea
Paroxysmal
Nocturnal
Dyspnea
Edema
Fatigue
Weight gain
In patients with heart failure:
New York Heart Association Class:
I: no symptoms
II: mild limitation during ordinary activity
III: Marked limitation in activity due to symptoms, comfortable only at rest
IV: symptoms at rest
  • Blood Pressure

  • Heart rate

  • Height

  • Weight

  • BMI

  • Jugular venous distension

  • Carotid Bruits

  • S3

  • S4

  • Murmur

  • Distal pulses

  • Rales

  • Wheezing

  • Hepatomegaly

  • Ascites

  • Edema (grade, extent)

Lab tests:
  • serum creatinine

  • brain natriuretic peptide

  • N-terminal pro-brain natriuretic peptide

  • Troponin I

  • Troponin T

  • Total cholesterol

  • Triglycerides

  • Low Density lipoprotein

  • High density lipoprotein

  • Aspirin

  • ACE-inhibitor

  • Angiotensin Receptor Blocker

  • Beta-blocker

  • Alpha blocker

  • Calcium channel blocker

  • Diuretics

  • Nitrates

  • Statin

  • Other lipid lowering therapy

  • Anticoagulant therapy

  • Other

Heart Failure/Cardiomyopathy
  • Heart failure with preserved Ejection Fraction

  • Heart Failure with Reduced Ejection Fraction

  • Etiology of Cardiomyopathy

  • Cardiac amyloidosis

  • Prior heart failure hospitalization

  • New York Heart Association Class

Echocardiography:
  • Left ventricular ejection fraction

  • Institutional lower limit of normal

  • Evidence of diastolic dysfunction (grade if present)

  • Evidence of moderate to severe valvular disease (list)

  • Left atrial dilation

  • Right atrial dilation

  • Right ventricular function

  • Right ventricular dilation

  • Regional wall motion abnormalities

Arrhythmias/ECG abnormalities
  • Atrial fibrillation

  • Atrial flutter

  • Other supraventricular tachycardia

  • Ventricular tachycardia

  • Ventricular fibrillation

  • Prior cardiac arrest

  • Long QT

  • Bradycardia

  • Sick sinus syndrome

  • Sinus tachycardia

  • Left bundle branch block

  • Arrhythmia - not otherwise listed

  • Syncope

  • Palpitations

  • Implantable Cardioverter Defibrillator

  • Pacemaker

Valvular Disease
  • Aortic stenosis

  • Aortic Regurgitation

  • Aortic valve repair or replacement

  • Mitral stenosis

  • Mitral regurgitation

  • Mitral valve prolapse

  • Mitral valve repair or replacement

  • Tricuspid stenosis

  • Tricuspid regurgitation

  • Tricuspid valve repair or replacement

  • Pulmonic stenosis

  • Pulmonic regurgitation

  • Endocarditis

Vascular disease
  • Carotid Disease

  • Transient Ischemic Attack

  • Stroke

  • Peripheral Vascular Disease

  • Thoracic Aortic Aneurysm

  • Abdominal Aortic Aneurysm

  • Deep Vein Thrombosis

  • Pulmonary Embolism

  • Pulmonary hypertension

Pericardial disease
  • Pericarditis

  • Pericardial Effusion

Cardiac Risk factors
  • Hypertension

  • Diabetes

  • Tobacco Use (prior or current)

  • Metabolic Syndrome

  • Obesity

  • Hyperlipidemia

  • Family history of cardiomyopathy or coronary artery disease

  • Alcohol use (>2 drinks/day)

  • Prior chest radiation (dose, fractions, field, date)

  • Prior anthracycline chemotherapy (agent, cumulative dose, year)

  • Anti-HER2 agent (agent, duration, year)